CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma
Clinical trial NCT07249073 · RECRUITING
Trial details
- NCT number
- NCT07249073
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2028-03-27
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.